Dr. Swati Patel, Group Head, DMPK & CP – Biologics, and Mr. Sushil Momaya – Manager, Business Development represented Advinus at the 9th Biosimilars Congregation 2016 in Mumbai on the 22nd of September. Advinus has evaluated more than a dozen Biosimilars for Toxicology studies for Indian DCGI and global regulatory submissions. Our Biosimilar offerings include Toxicology, Toxicokinetics, Pharmacokinetics, Pharmacodynamics, Biomarker Analysis and Immunogenicity Assessment.
Advinus Exhibited at the 9th Biosimilars Congregation 2016, Mumbai
Home / Advinus Exhibited at the 9th Biosimilars Congregation 2016, Mumbai